title: Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
authors.forename: Marcus W
authors.initials: MW
authors.lastname: Koch
authors.forename: Jop P
authors.initials: JP
authors.lastname: Mostert
authors.forename: Joeke J
authors.initials: JJ
authors.lastname: de Vries
authors.forename: Jacques
authors.initials: J
authors.lastname: De Keyser
mesh_terms: D001930:Brain Injuries / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D018450:Disease Progression; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D016899:Interferon-beta